| MM29B:
On bead digest from HLA-I IP of patient plasmas. The purpose is to assess differences in HLA-I abundance/shadding between patients.
Reduced/Alkylated, Trypsin digested, TMTpro labelled, premix (not cleaned up, but dried and resuspended in 0.1%TFA), the actual sample will be cleaned up. |